NASDAQ:SRRK Scholar Rock (SRRK) Stock Price, News & Analysis $34.15 +0.08 (+0.22%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Scholar Rock Stock (NASDAQ:SRRK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Scholar Rock alerts:Sign Up Key Stats Today's Range$33.78▼$34.5450-Day Range$24.47▼$34.3852-Week Range$6.76▼$46.98Volume65,816 shsAverage Volume1.28 million shsMarket Capitalization$3.24 billionP/E RatioN/ADividend YieldN/APrice Target$42.67Consensus RatingBuy Company OverviewScholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.Read More… Scholar Rock Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks91st Percentile Overall ScoreSRRK MarketRank™: Scholar Rock scored higher than 91% of companies evaluated by MarketBeat, and ranked 321st out of 1,886 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingScholar Rock has received a consensus rating of Buy. The company's average rating score is 3.14, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageScholar Rock has only been the subject of 2 research reports in the past 90 days.Read more about Scholar Rock's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Scholar Rock are expected to grow in the coming year, from ($2.42) to ($2.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Scholar Rock is -14.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Scholar Rock is -14.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioScholar Rock has a P/B Ratio of 10.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Scholar Rock's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted20.11% of the float of Scholar Rock has been sold short.Short Interest Ratio / Days to CoverScholar Rock has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.Change versus previous monthShort interest in Scholar Rock has recently decreased by 11.47%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldScholar Rock does not currently pay a dividend.Dividend GrowthScholar Rock does not have a long track record of dividend growth. Sustainability and ESG4.4 / 5Environmental Score-1.01 Percentage of Shares Shorted20.11% of the float of Scholar Rock has been sold short.Short Interest Ratio / Days to CoverScholar Rock has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.Change versus previous monthShort interest in Scholar Rock has recently decreased by 11.47%, indicating that investor sentiment is improving significantly. News and Social Media3.9 / 5News Sentiment1.09 News SentimentScholar Rock has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Scholar Rock this week, compared to 7 articles on an average week.Search Interest2 people have searched for SRRK on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows3 people have added Scholar Rock to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Scholar Rock insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,284,738.00 in company stock.Percentage Held by Insiders13.30% of the stock of Scholar Rock is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions91.08% of the stock of Scholar Rock is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Scholar Rock's insider trading history. Receive SRRK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scholar Rock and its competitors with MarketBeat's FREE daily newsletter. Email Address SRRK Stock News HeadlinesInsider Selling: Scholar Rock Holding Co. (NASDAQ:SRRK) Director Sells 3,375 Shares of StockMay 31, 2025 | insidertrades.comScholar Rock (NASDAQ:SRRK) Upgraded at Lifesci CapitalJune 6, 2025 | americanbankingnews.comThe Robotics Revolution has arrived … and one $7 stock could take off as a result.It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we've imagined robots doing things like cleaning our homes, serving drinks at restaurants, greeting guests in hotel lobbies, stacking shelves in warehouses, and so on. Very soon, there will be a robot that won't do any of that. However, it's impact on the US economy and society will be FAR greater than anything we ever imagined.June 10, 2025 | Weiss Ratings (Ad)Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General ManagerJune 2, 2025 | uk.finance.yahoo.comScholar Rock to Present at the Jefferies Global Healthcare ConferenceMay 28, 2025 | businesswire.comScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 16, 2025 | businesswire.comEarnings call transcript: Scholar Rock’s Q1 2025 results show slight EPS miss, stock reacts positivelyMay 15, 2025 | investing.comEarnings call transcript: Scholar Rock’s Q1 2025 results show slight EPS miss, stock reacts positivelyMay 15, 2025 | investing.comSee More Headlines SRRK Stock Analysis - Frequently Asked Questions How have SRRK shares performed this year? Scholar Rock's stock was trading at $43.22 at the beginning of 2025. Since then, SRRK shares have decreased by 21.2% and is now trading at $34.07. View the best growth stocks for 2025 here. How were Scholar Rock's earnings last quarter? Scholar Rock Holding Co. (NASDAQ:SRRK) released its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.67) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.04. Read the conference call transcript. When did Scholar Rock IPO? Scholar Rock (SRRK) raised $76 million in an IPO on Thursday, May 24th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets acted as the underwriters for the IPO and Wedbush PacGrow was co-manager. Who are Scholar Rock's major shareholders? Scholar Rock's top institutional investors include Price T Rowe Associates Inc. MD (9.38%), Vanguard Group Inc. (5.11%), Redmile Group LLC (4.64%) and Eventide Asset Management LLC (2.81%). Insiders that own company stock include Public Equities LP Invus, Samsara Biocapital Gp, Llc, Srinivas Akkaraju, Amir Nashat, Akshay Vaishnaw, Jay T Backstrom, Junlin Ho, Caryn Parlavecchio, Edward H Myles, Mo Qatanani, Tracey Sacco, Jing L Marantz, Michael Gilman, Katie Peng, Jeffrey S Flier, Kristina Burow and Joshua Reed. View institutional ownership trends. How do I buy shares of Scholar Rock? Shares of SRRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Scholar Rock own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scholar Rock investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), First Solar (FSLR) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/14/2025Today6/10/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:SRRK CIK1727196 Webwww.scholarrock.com Phone(857) 259-3860Fax866-493-4935Employees140Year FoundedN/APrice Target and Rating Average Stock Price Target$42.67 High Stock Price Target$50.00 Low Stock Price Target$31.00 Potential Upside/Downside+25.2%Consensus RatingBuy Rating Score (0-4)3.14 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($2.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$165.79 million Net MarginsN/A Pretax MarginN/A Return on Equity-145.60% Return on Assets-91.83% Debt Debt-to-Equity Ratio0.63 Current Ratio3.88 Quick Ratio3.88 Sales & Book Value Annual Sales$33.19 million Price / Sales97.46 Cash FlowN/A Price / Cash FlowN/A Book Value$3.12 per share Price / Book10.92Miscellaneous Outstanding Shares94,946,000Free Float75,641,000Market Cap$3.23 billion OptionableOptionable Beta0.28 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:SRRK) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scholar Rock Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scholar Rock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.